Overview

An Open-Label Study to Assess Safety

Status:
Unknown status
Trial end date:
2019-12-15
Target enrollment:
Participant gender:
Summary
An Open-Label study to assess safety
Phase:
Phase 2
Details
Lead Sponsor:
Taro Pharmaceuticals USA